Predictive Score for Significant Diastolic Dysfunction in Patients with Morbid Obesity Undergoing Bariatric Surgery.

IF 7.9 Q1 ENDOCRINOLOGY & METABOLISM
Aphichat Suphathamwit, Kamheang Vacharaksa, Chaowanan Khamtuikrua, Chanakan Jerdmathawut, Voraboot Taweerutchana, Chutharat Wetchakama, Nipaporn Sangarunakul
{"title":"Predictive Score for Significant Diastolic Dysfunction in Patients with Morbid Obesity Undergoing Bariatric Surgery.","authors":"Aphichat Suphathamwit, Kamheang Vacharaksa, Chaowanan Khamtuikrua, Chanakan Jerdmathawut, Voraboot Taweerutchana, Chutharat Wetchakama, Nipaporn Sangarunakul","doi":"10.7570/jomes25019","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Morbid obesity is a well-established risk factor for cardiovascular disease. Diastolic dysfunction, particularly in non-cardiac surgeries, has been associated with increased incidence of adverse cardiovascular events. This study aimed to evaluate the prevalence of diastolic dysfunction in morbidly obese patients undergoing bariatric surgery and to identify associated clinical risk factors using transesophageal echocardiography (TEE).</p><p><strong>Methods: </strong>In this prospective observational study, 113 morbidly obese patients scheduled for bariatric surgery between April 2019 and January 2023 were enrolled. Diastolic function was assessed after anesthesia induction using TEE and categorized as normal or grade I, II, or III dysfunction based on the E/e' ratio. The primary study outcome was the prevalence of diastolic dysfunction, while secondary outcomes included identification of risk factors, development of a predictive score and evaluation of perioperative complications.</p><p><strong>Results: </strong>Diastolic dysfunction was identified in 45.1% of patients (grade I: 21.2%; grade II: 19.5%; and grade III: 4.4%). Age (odds ratio [OR], 1.04; 95% confidence interval [CI], 1.01 to 1.08) and continuous positive airway pressure (CPAP) use for obstructive sleep apnea (OSA) (OR, 4.22; 95% CI, 1.02 to 17.55) were significantly associated with high-grade dysfunction (grades II-III). A predictive score demonstrated high diagnostic accuracy with a cutoff of >120 points. The score was calculated as (age×2)+(coronary artery disease×51)+(chronic kidney disease×102)+(OSA without CPAP×2)+(OSA with CPAP×63). Postoperative outcomes did not differ significantly between groups.</p><p><strong>Conclusion: </strong>Diastolic dysfunction is prevalent among morbidly obese patients undergoing bariatric surgery. A predictive score exceeding 120 points may aid in identifying individuals at elevated risk.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":" ","pages":""},"PeriodicalIF":7.9000,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Obesity & Metabolic Syndrome","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7570/jomes25019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Morbid obesity is a well-established risk factor for cardiovascular disease. Diastolic dysfunction, particularly in non-cardiac surgeries, has been associated with increased incidence of adverse cardiovascular events. This study aimed to evaluate the prevalence of diastolic dysfunction in morbidly obese patients undergoing bariatric surgery and to identify associated clinical risk factors using transesophageal echocardiography (TEE).

Methods: In this prospective observational study, 113 morbidly obese patients scheduled for bariatric surgery between April 2019 and January 2023 were enrolled. Diastolic function was assessed after anesthesia induction using TEE and categorized as normal or grade I, II, or III dysfunction based on the E/e' ratio. The primary study outcome was the prevalence of diastolic dysfunction, while secondary outcomes included identification of risk factors, development of a predictive score and evaluation of perioperative complications.

Results: Diastolic dysfunction was identified in 45.1% of patients (grade I: 21.2%; grade II: 19.5%; and grade III: 4.4%). Age (odds ratio [OR], 1.04; 95% confidence interval [CI], 1.01 to 1.08) and continuous positive airway pressure (CPAP) use for obstructive sleep apnea (OSA) (OR, 4.22; 95% CI, 1.02 to 17.55) were significantly associated with high-grade dysfunction (grades II-III). A predictive score demonstrated high diagnostic accuracy with a cutoff of >120 points. The score was calculated as (age×2)+(coronary artery disease×51)+(chronic kidney disease×102)+(OSA without CPAP×2)+(OSA with CPAP×63). Postoperative outcomes did not differ significantly between groups.

Conclusion: Diastolic dysfunction is prevalent among morbidly obese patients undergoing bariatric surgery. A predictive score exceeding 120 points may aid in identifying individuals at elevated risk.

接受减肥手术的病态肥胖患者显著舒张功能障碍的预测评分
背景:病态肥胖是公认的心血管疾病的危险因素。舒张功能障碍,特别是在非心脏手术中,与不良心血管事件的发生率增加有关。本研究旨在评估接受减肥手术的病态肥胖患者舒张功能障碍的患病率,并利用经食管超声心动图(TEE)确定相关的临床危险因素。方法:在这项前瞻性观察研究中,纳入了113名计划于2019年4月至2023年1月进行减肥手术的病态肥胖患者。麻醉诱导后使用TEE评估舒张功能,并根据E/ E比值将其分为正常或I、II、III级功能障碍。主要研究结果是舒张功能不全的发生率,次要结果包括危险因素的识别、预测评分的制定和围手术期并发症的评估。结果:45.1%的患者存在舒张功能障碍(I级:21.2%,II级:19.5%,III级:4.4%)。年龄(优势比[OR], 1.04; 95%可信区间[CI], 1.01至1.08)和持续使用气道正压通气(CPAP)治疗阻塞性睡眠呼吸暂停(OSA) (OR, 4.22; 95% CI, 1.02至17.55)与高度功能障碍(II-III级)显著相关。预测评分显示出较高的诊断准确性,临界值为bbbb120分。积分计算为(age×2)+(冠状动脉disease×51)+(慢性肾脏disease×102)+(OSA不伴CPAP×2)+(OSA伴CPAP×63)。两组术后结果无显著差异。结论:舒张功能障碍在接受减肥手术的病态肥胖患者中普遍存在。超过120分的预测分数可能有助于识别高危人群。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Obesity & Metabolic Syndrome
Journal of Obesity & Metabolic Syndrome ENDOCRINOLOGY & METABOLISM-
CiteScore
8.30
自引率
9.60%
发文量
39
审稿时长
19 weeks
期刊介绍: The journal was launched in 1992 and diverse studies on obesity have been published under the title of Journal of Korean Society for the Study of Obesity until 2004. Since 2017, volume 26, the title is now the Journal of Obesity & Metabolic Syndrome (pISSN 2508-6235, eISSN 2508-7576). The journal is published quarterly on March 30th, June 30th, September 30th and December 30th. The official title of the journal is now "Journal of Obesity & Metabolic Syndrome" and the abbreviated title is "J Obes Metab Syndr". Index words from medical subject headings (MeSH) list of Index Medicus are included in each article to facilitate article search. Some or all of the articles of this journal are included in the index of PubMed, PubMed Central, Scopus, Embase, DOAJ, Ebsco, KCI, KoreaMed, KoMCI, Science Central, Crossref Metadata Search, Google Scholar, and Emerging Sources Citation Index (ESCI).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信